Clinical Trial Update: Safety and Immunogenicity of Catch-up Vaccination Regimens of V114 (V114-024) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating safety and immunogenicity of catch-up vaccination regimens for V114; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• V114 (15-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pneumococcal Infections | Phase 3 | Status: COMPLETED | Results posted: 2021-09-23